These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17785962)

  • 21. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
    Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
    Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
    Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
    Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
    Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
    Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
    Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
    Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia.
    Brezinova J; Berkova A; Vcelikova S; Zemanova Z; Izakova S; Sarova I; Cechova H; Tajtlova J; Grosova L; Lizcova L; Malinova E; Zemanova M; Cmunt E; Karban J; Trneny M; Schwarz J; Michalova K
    Neoplasma; 2010; 57(3):215-21. PubMed ID: 20353271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
    Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD38 as a prognostic marker in CLL.
    Matrai Z
    Hematology; 2005 Feb; 10(1):39-46. PubMed ID: 16019444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil.
    Morabito F; Mangiola M; Stelitano C; Deaglio S; Callea V; Malavasi F
    Haematologica; 2002 Feb; 87(2):217-8. PubMed ID: 11836173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
    Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
    Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity.
    Alsuwaidan A; Pirruccello E; Jaso J; Koduru P; Garcia R; Krueger J; Doucet M; Chaudhry R; Fuda F; Chen W
    Cytometry B Clin Cytom; 2019 Sep; 96(5):368-374. PubMed ID: 30734478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse.
    Martín-Moro F; Roncancio A; Benito A; Talavera M; Villarrubia J; Blanchard MJ
    Ann Hematol; 2020 Nov; 99(11):2705-2706. PubMed ID: 32458065
    [No Abstract]   [Full Text] [Related]  

  • 37. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
    Hulkkonen J; Vilpo L; Hurme M; Vilpo J
    Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
    Hsi ED; Kopecky KJ; Appelbaum FR; Boldt D; Frey T; Loftus M; Hussein MA
    Br J Haematol; 2003 Mar; 120(6):1017-25. PubMed ID: 12648072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
    Calissano C; Damle RN; Hayes G; Murphy EJ; Hellerstein MK; Moreno C; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
    Blood; 2009 Nov; 114(23):4832-42. PubMed ID: 19789386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
    Ibrahim S; Keating M; Do KA; O'Brien S; Huh YO; Jilani I; Lerner S; Kantarjian HM; Albitar M
    Blood; 2001 Jul; 98(1):181-6. PubMed ID: 11418478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.